| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 11 Aug 2025 | 2 Aug 2025 |
| To consider and approve the financial results for the period ended Jun 30, 2025 and other business matters | ||
| Board Meeting | 19 May 2025 | 11 May 2025 |
| To consider and approve the financial results for the period ended March 31, 2025 Jfl Life Sciences Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025 (As Per NSE Announcement Dated On : 19.05.2025) Jfl Life Sciences Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025. (As Per NSE Announcement dated On : 28.06.2025) | ||
| Board Meeting | 22 Apr 2025 | 22 Apr 2025 |
| Jfl Life Sciences Limited has informed the Exchange regarding Board meeting held on April 22, 2025 | ||
| Board Meeting | 8 Apr 2025 | 3 Apr 2025 |
| JFL LIFE SCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 08-APR-2025 to inter-alia consider and approve the Unaudited Financial results of the Company along with limited review report for the Quarter and nine months ended 31 December, 2024 Jfl Life Sciences Limited has informed the Exchange regarding Board meeting held on April 08, 2025. (As Per NSE Announcement Dated on: 08.04.2025) | ||
| Board Meeting | 27 Mar 2025 | 19 Mar 2025 |
| To consider Fund Raising in Board Meeting by way of Issue Of Shares On Right Issue Basis To The Existing Shareholders Of The Company. Jfl Life Sciences Limited has informed the Exchange regarding Board meeting held on March 27, 2025. (As Per NSE Announcement Date on : 27.03.2025) Jfl Life Sciences Limited has informed the Exchange regarding Outcome of Board Meeting held on April 08, 2025 (As Per NSE Announcement dated On : 09.04.2025) | ||
| Board Meeting | 14 Nov 2024 | 5 Nov 2024 |
| To consider and approve the financial results for the period ended September 30, 2024 Jfl Life Sciences Limited has informed the Exchange regarding Board meeting held on November 14, 2024. (As Per NSE Announcement Dated on: 14/11/2024) | ||
| Board Meeting | 4 Oct 2024 | 4 Oct 2024 |
| Jfl Life Sciences Limited has informed the Exchange regarding Outcome of Board Meeting held on October 04, 2024. | ||
| Board Meeting | 31 Aug 2024 | 23 Aug 2024 |
| To consider other business matters as follows: 1. To consider and approve the Director s Report along with the annexures for the year ending 31st March, 2024.2. To consider and approve the Notice of 14th Annual General Meeting for the year ending 31st March, 2024.3. To consider appointment of M/s. Prachi Prajapati & Associates., Practising Company Secretaries as Scrutinizers for e-voting process to be conducted at the ensuing 14th Annual General Meeting of the company.4. To consider the appointment of M/s Prachi Prajapati & Associates, Practising Company Secretaries as Secretarial Auditor of the Company for FY 2024-25.5. To consider the appointment of P H P & Associates, Chartered Accountants as Internal Auditor of the Company for FY 2024-25.6. Any other business with the permission of the chair and the majority of the directors present at the meeting. Jfl Life Sciences Limited has informed the Exchange regarding Board meeting held on August 31, 2024. (As Per NSE Announcement Dated on: 31/08/2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.